TrialJournal of clinical hypertension (Greenwich, Conn.)

Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements.

Joel M Neutel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.